Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04040 (
Catalase
)
3,577
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The peroxisome proliferator-activated receptor gamma (
PPAR gamma
) plays an important role in vascular regulation. However, the impact of oxidative stress on
PPAR gamma
expression and activity has not been clearly defined. Human umbilical vein endothelial cells (HUVECs) were exposed to graded concentrations of H(2)O(2) for 0.5-72h, or bovine aortic endothelial cells (BAECs) were exposed to alterations in extracellular thiol/disulfide redox potential (E(h)) of the cysteine/cystine couple. Within 2h, H(2)O(2) reduced HUVEC
PPAR gamma
mRNA and activity and reduced the expression of two
PPAR gamma
-regulated genes without altering
PPAR gamma
protein levels. After 4h H(2)O(2) exposure, mRNA levels remained reduced, whereas
PPAR gamma
activity returned to control levels.
PPAR gamma
mRNA levels remained depressed for up to 72 h after exposure to H(2)O(2), without any change in
PPAR gamma
activity.
Catalase
prevented H(2)O(2)-induced reductions in
PPAR gamma
mRNA and activity. H(2)O(2) (1) reduced luciferase expression in HUVECs transiently transfected with a human
PPAR gamma
promoter reporter, (2) failed to alter
PPAR gamma
mRNA half-life, and (3) transiently increased expression and activity of c-Fos and phospho-c-Jun. Treatment with the AP1 inhibitor curcumin prevented H(2)O(2)-mediated reductions in
PPAR gamma
expression. In addition, medium having an oxidized E(h) reduced BAEC
PPAR gamma
mRNA and activity. These findings demonstrate that oxidative stress, potentially through activation of inhibitory redox-regulated transcription factors, attenuates
PPAR gamma
expression and activity in vascular endothelial cells through suppression of
PPAR gamma
transcription.
...
PMID:Oxidative stress modulates PPAR gamma in vascular endothelial cells. 2030 27